Books in Neoplastic cancer pharmacology

1-10 of 19 results in All results

Medicinal Chemistry of Anticancer Drugs

• 3rd Edition
• April 28, 2023
• Carmen Avendaño + 1 more
• English
• Paperback 978-0-12-818549-0

  9 7 8 - 0 - 1 2 - 8 1 8 5 4 9 - 0
• eBook 978-0-12-819652-6

  9 7 8 - 0 - 1 2 - 8 1 9 6 5 2 - 6

This third edition of Medicinal Chemistry of Anticancer Drugs, provides an updated resource for students and researchers from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. This new edition includes updated sections on the hot topic of cancer immunotherapy, cancer polypharmacology, multitargeted cancer therapy, medicinal chemistry of cancer diagnosis, theranostic anticancer agents, and pre-mRNA processing in cancer. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a unique and valuable perspective from the point of view of medicinal chemistry and drug design. It will be useful to undergraduate and postgraduate students of medicinal chemistry, pharmacology, biological chemistry, pharmacy and other health sciences. Researchers and practitioners will find a comprehensive treatment of the topic and a large number of references to reviews and the primary literature.

Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics

• 1st Edition
• July 25, 2022
• Sunny Ohia + 1 more
• English
• Paperback 978-0-12-819291-7

  9 7 8 - 0 - 1 2 - 8 1 9 2 9 1 - 7
• eBook 978-0-12-819292-4

  9 7 8 - 0 - 1 2 - 8 1 9 2 9 2 - 4

Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics provides a review of the basic anatomy, physiology, biochemistry and pathology of the eye with a focus drug therapy, drug delivery and use of therapeutic medical miniature devices. An understanding of the pharmacological actions of drugs acting on the eye requires the student and health care practitioner to learn additional principles in basic and clinical sciences that are unique to this organ. As a sensory organ, the eye is relatively inaccessible to the systemic circulation due to the blood-vitreous, blood-aqueous and blood-retinal barriers. Consequently, the administration of drugs for therapeutic effects in the eye necessitates an understanding of physico-chemical properties of the molecules and pharmacokinetic principles involved in the access to its site of action via topical, intracameral and intravitreal administration. This book includes information on the general principles of pharmacokinetics and pharmacodynamics of drugs as it pertains to the eye and in combating ocular disorders and diseases. Using a disease-themed approach, the book discusses basic and clinical pharmacological principles involved in the therapy of these diseases including the ocular side effect of systemically-administered drugs, drugs used in ophthalmic surgery and miscellaneous agents, the therapeutic utility of biologics, drug conjugates, combination products, gene and cellular therapy are also covered. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics is useful as a primary and secondary source of reference for up-to-date information about the pharmacological mechanisms of action, pharmacokinetics, side effects, drug-drug interactions and therapeutic indications of drugs for pharmacologists, pharmaceutical scientists, students in the health care disciplines (nursing, pharmacy, optometry, medical), and practitioners in optometry and ophthalmology.

Lanzkowsky's Manual of Pediatric Hematology and Oncology

• 7th Edition
• June 1, 2021
• Jonathan D. Fish + 2 more
• English
• Hardback 978-0-12-821671-2

  9 7 8 - 0 - 1 2 - 8 2 1 6 7 1 - 2
• eBook 978-0-323-85361-3

  9 7 8 - 0 - 3 2 3 - 8 5 3 6 1 - 3

Lanzkowsky’s Manual of Pediatric Hematology and Oncology, Seventh Edition remains the go-to clinical manual for the treatment and management of childhood cancers and blood disorders. It is a comprehensive book on patient management, replete with algorithms and flow diagrams, and includes a new section on vascular anomalies. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the seventh edition of this successful clinical manual is entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format, again, enables readers to make accurate diagnoses and treatment decisions without having to reference larger medical textbooks.

Diagnostic and Therapeutic Applications of Exosomes in Cancer

• 1st Edition
• May 9, 2018
• Mansoor M. Amiji + 1 more
• English
• Hardback 978-0-12-812774-2

  9 7 8 - 0 - 1 2 - 8 1 2 7 7 4 - 2
• eBook 978-0-12-812804-6

  9 7 8 - 0 - 1 2 - 8 1 2 8 0 4 - 6

Diagnostic and Therapeutic Applications of Exosomes in Cancer evaluates the potential of exosome content manipulation in the development of novel therapeutics. In recent years, exosomes, the small vesicles produced by all cell types, have been identified as contributors to cancer growth and metastasis. However, due to their unique biophysical properties, they are also being tested for use in therapeutic design and delivery, as well as in diagnostics. This book presents a comprehensive analysis on exosomes, with a main emphasis on their biogenesis and signaling, use as biomarkers, and as tools for imaging, drug delivery and the treatment of cancer.

Peptidomics of Cancer-Derived Enzyme Products

• 1st Edition
• Volume 42
• October 18, 2017
• Tony Y. Hu + 1 more
• English
• Hardback 978-0-12-812638-7

  9 7 8 - 0 - 1 2 - 8 1 2 6 3 8 - 7
• eBook 978-0-12-812639-4

  9 7 8 - 0 - 1 2 - 8 1 2 6 3 9 - 4

Peptidomics of Cancer-Derived Enzyme Products, Volume 42, the latest in The Enzymes series, is ideal for researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, with this volume featuring high-caliber, thematic articles on the topic of peptidomics of cancer-derived enzyme products. Specific chapters cover Circulating peptidome and tumor-resident proteolysis, Colon tumor secretopeptidome, Chemoenzymatic method for glycomics, Human plasma peptidome for pancreatic cancer, Lipoproteomics and quantitative proteomics, Salivaomics: Protein markers/extracellular RNA/DNA in saliva, and Enzyme-responsive vectors for cancer therapy.

Cardio-Oncology

• 1st Edition
• November 26, 2016
• Roberta A. Gottlieb + 1 more
• English
• Hardback 978-0-12-803547-4

  9 7 8 - 0 - 1 2 - 8 0 3 5 4 7 - 4
• eBook 978-0-12-803553-5

  9 7 8 - 0 - 1 2 - 8 0 3 5 5 3 - 5

Cardio-Oncology: Principles, Prevention and Management is a clinical volume that focuses on the basic science of cardio-oncology, addresses cardiotoxicity as a consequence of cancer therapy, and discusses prevention, diagnosis and management of cardiovascular disease in patients with cancer. This comprehensive volume presents unique perspectives ranging from basic science to clinical medicine in the field of cardio-oncology. It would be a valuable resource for cardiologists, oncologists, internists, and pediatricians caring for patients with cancer who have cardiovascular risk factors, as well as for cardio-oncology researchers.

Lanzkowsky's Manual of Pediatric Hematology and Oncology

• 6th Edition
• April 22, 2016
• Jonathan D. Fish + 2 more
• English
• eBook 978-0-12-801674-9

  9 7 8 - 0 - 1 2 - 8 0 1 6 7 4 - 9

Lanzkowsky’s Manual of Pediatric Hematology and Oncology, Sixth Edition, is a comprehensive book on patient management, replete with algorithms and flow diagrams on diagnosis and management. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the sixth edition of this successful clinical manual has been entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format will enable readers to make accurate diagnoses and permit them to treat patients without having to reference larger medical textbooks. Based on the new standards of genetic classification and prognostic information that have arisen in the past five years, the sixth edition includes two new chapters (Diagnostic, Molecular, and Genomic Methodologies for the Hematologist, Transfusion Medicine) and several new expanded chapters that were previously sections in consolidated chapters (Myelodysplasia, Myeloid Leukemias, Lymphoid Leukemias, Hemolytic Anemia, and Disorders of Coagulation).

Advances in Cancer Research

• 1st Edition
• Volume 127
• June 18, 2015
• Kenneth D. Tew + 1 more
• English
• Hardback 978-0-12-802920-6

  9 7 8 - 0 - 1 2 - 8 0 2 9 2 0 - 6
• eBook 978-0-12-802942-8

  9 7 8 - 0 - 1 2 - 8 0 2 9 4 2 - 8

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics, including taxane-anti-androgens cross-resistance in advanced prostate cancer and proteasome inhibitors in the treatment of multiple myeloma.

Anti-Angiogenesis Drug Discovery and Development

• 1st Edition
• June 2, 2015
• Atta-ur Rahman + 1 more
• English
• Paperback 978-0-12-803963-2

  9 7 8 - 0 - 1 2 - 8 0 3 9 6 3 - 2
• eBook 978-0-12-803964-9

  9 7 8 - 0 - 1 2 - 8 0 3 9 6 4 - 9

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. These reader-friendly chapters cover topics of great scientific importance, many of which are considered significant medical breakthroughs, making this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.

Medicinal Chemistry of Anticancer Drugs

• 2nd Edition
• April 28, 2015
• Carmen Avendaño + 1 more
• English
• Paperback 978-0-444-62649-3

  9 7 8 - 0 - 4 4 4 - 6 2 6 4 9 - 3
• eBook 978-0-444-62667-7

  9 7 8 - 0 - 4 4 4 - 6 2 6 6 7 - 7

Medicinal Chemistry of Anticancer Drugs, Second Edition, provides an updated treatment from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells, and resistance to antitumor drugs continues to be investigated. While these therapies are in their infancy, they hold promise of more effective therapies with fewer side effects. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a sorely needed update from the point of view of medicinal chemistry and drug design.